The CHB therapeutics market offers growth opportunities via emerging functional cures like bepirovirsen and selgantolimod, amidst challenges from patent expiries and generic erosion. Strategic R&D, ...
SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...
Preliminary total global full year 2025 revenue of approximately $616 millionPreliminary BRIUMVI U.S. fourth quarter and full year 2025 net ...
Aligos Therapeutics, Inc. ("Aligos”, Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient ...
Research shows that compliance-focused safety training alone rarely delivers lasting risk reduction, prompting calls for ...
An international collaborative study published in Science Bulletin reveals that over 680,000 new cases of hepatocellular ...
The Nation on MSNOpinion
Trump’s Death Eaters Are Coming for Our Kids
After taking countless lives around the world, RFK Jr. and his ghoulish compatriots want American children to suffer too.
Detailed price information for Autolus Therapeutics Plc ADR (AUTL-Q) from The Globe and Mail including charting and trades.
Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and conduit infection increased initial hospital charges by ...
A federal panel decided to delay the birth dose of hepatitis b vaccine unless there is maternal hepatitis b blood test ...
Opinion
My grandfather created the hepatitis B vaccine. Would he recognize public health in the U.S. today?
Physician Emilie G.C. Thompson’s grandfather created the hepatitis B vaccine. Now she’s watching his legacy get dismantled.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback